• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Artificial Organs

3D printing and cryogenics could create new potential for artificial organs

January 17, 2018 By Danielle Kirsh

Researchers at Imperial College London have developed a technique to replicate biological structures using cryogenics and 3D printing. The research is a first from the university to create structures that are soft enough to replicate the mechanical properties of organs like the brain and lungs. The 3D printing technique could create replica organs and assist […]

Filed Under: Regenerative Medicine, Research & Development Tagged With: Artificial Organs, Imperial College London, MedTech

Carmat gains on French approval to resume artificial heart trial

May 3, 2017 By Brad Perriello

Carmat (EPA:ALCAR) shares are up today after the company said French regulators approved the resumption of a clinical trial for its artificial heart. France’s national device & drug agency, the Agence Nationale de Sécurité du Médicament, said late yesterday that “Carmat has provided the elements allowing for the resumption of the trial, meeting satisfactory conditions of safety and […]

Filed Under: Structural Heart, Wall Street Beat Tagged With: Artificial Organs, Carmat Inc.

Tissue-engineered human liver made from stem & progenitor cells

September 15, 2016 By Sarah Faulkner

Researchers at the Saban Research Institute of Children’s Hospital in Los Angeles generated mouse and human tissue-engineered livers from organoid units composed of stem and progenitor cells, according to a study published in Stem Cells Translational Medicine last month. The tissue-engineered liver demonstrated normal attributes such as hepatocytes and blood cells and even restored some […]

Filed Under: Stem Cells Tagged With: Artificial Organs, Children's Hospital Los Angeles

SynCardia pulls $28m IPO

October 14, 2015 By Brad Perriello

SynCardia Systems yesterday withdrew its plans for an initial public offering that was slated to fetch $27.5 million at the midpoint. “The registrant submits this request for withdrawal as it does not intend to pursue the contemplated public offering at this time,” the Tucson-based artificial heart maker said in an SEC filing. Syncardia had planned to float […]

Filed Under: Funding Roundup, Initial Public Offering (IPO) Tagged With: Artificial Organs, SynCardia

Carmat to give 4th patient artificial heart within 3 months

June 3, 2015 By Brad Perriello

(Reuters) — Carmat (FRA:CXT) will equip a 4th patient with an artificial heart within 3 months at most, 1 of the company’s founders told BFM television today. The French company is conducting trials of its heart device, which is designed as a permanent implant to extend the life of patients without them having to wait for a […]

Filed Under: Cardiovascular, Structural Heart Tagged With: Artificial Organs

Carmat: No problem with artificial heart fundamentals despite death

May 6, 2015 By MassDevice Leave a Comment

Carmat: No problem with artificial heart fundamentals despite death

Filed Under: News Well, Structural Heart Tagged With: Artificial Organs, Carmat Inc., Clinical Trials

Euronext suspends Carmat shares after artificial heart patient dies

May 5, 2015 By MassDevice

Euronext suspends Carmat shares after artificial heart patient dies

Filed Under: News Well, Respiratory, Structural Heart, Wall Street Beat Tagged With: Artificial Organs, Carmat Inc., Euronext

Carmat artificial heart patient ‘never felt so good’

April 6, 2015 By MassDevice Leave a Comment

Carmat artificial heart patient 'never felt so good'

Filed Under: News Well, Structural Heart Tagged With: Artificial Organs, Carmat Inc., Clinical Trials

Carmat shares surge on artificial heart patient’s hospital discharge

January 20, 2015 By MassDevice Leave a Comment

Carmat shares surge on artificial heart patient's hospital discharge

Filed Under: News Well, Structural Heart Tagged With: Artificial Organs, Carmat Inc.

Vital Therapies prices $54M IPO

April 17, 2014 By Brad Perriello Leave a Comment

Vital Therapies prices $54M IPO

Vital Therapies priced its initial public offering at $12 per share, once again lowering the bar for its 1st public flotation after scuttling its 1st try at a U.S. IPO.

Vital Therapies, which is developing a bio-artificial liver, last October set the IPO’s price range at $16-$18. But the San Diego-based company but shelved the offering until March, when it set the range at $13-$15 per share.

Filed Under: Initial Public Offering (IPO), News Well, Wall Street Beat Tagged With: Artificial Organs, NASDAQ, Vital Therapies

Vital Therapies lowers the bar with 2nd IPO try

April 7, 2014 By Brad Perriello Leave a Comment

Vital Therapies lowers the bar with 2nd IPO try

Bio-artificial liver maker Vital Therapies set the range for its initial public offering at $13 to $15 per share, below the $16 to $18 range it set last year before scuttling its 1st try at a U.S. IPO.

In March Vital Therapies filed updated registration statements signaling its intent to launch the IPO, wiping clean the pricing set in November 2013. Another filing today set the new price range for the 4.5-million-share offering at $58.5 million to $67.5 million.

Filed Under: Initial Public Offering (IPO), News Well, Wall Street Beat Tagged With: Artificial Organs, NASDAQ, Vital Therapies

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS